Featured Research

from universities, journals, and other organizations

Facts in scientific drug literature may not be

Date:
May 29, 2012
Source:
University of Illinois at Chicago
Summary:
A growing concern with fraud and misconduct in published drug studies has led researchers to investigate the extent and reasons for retractions in the research.

A growing concern with fraud and misconduct in published drug studies has led researchers at the University of Illinois at Chicago's Center for Pharmacoeconomic Research to investigate the extent and reasons for retractions in the research.

Related Articles


"We were surprised to find the proportion of retractions due to scientific misconduct in the drug literature is higher than in general biomedical literature," said Simon Pickard, associate professor of pharmacy practice and senior author of a study published in the journal Pharmacotherapy.

Nearly three-quarters of the retracted drug studies were attributed to scientific misconduct, he said, "which includes data falsification or fabrication, questionable veracity, unethical author conduct, or plagiarism. While these studies comprise a small percentage of the overall literature, health care professionals may rely on this evidence to make treatment recommendations."

These studies can affect the treatment of thousands of patients, since scientific publications are often printed months in advance. There is an average lag in time of 39 months between the original publication and a retraction notice, Pickard said.

"Once a health care professional changes treatment options, it's not easy to reverse," said Jennifer Samp, a fellow in Pickard's research group and lead author of the study. "Staying current with new findings in scientific literature is a priority for health care practitioners -- especially pharmacists -- and it is important for them to know when a study has been retracted, especially those with manipulated data."

The UIC team found that a considerable number of the retracted papers were attributable to two authors, one based in Japan and the other in Germany.

Little attention was paid to the implications of scientific publication retractions until a 1998 review documented 235 instances from 1966 to 1997; 37 percent of the retractions were due to scientific misconduct.

Since the 1998 study, more interest has been given to retracted studies. In 2009, the Committee on Publication Ethics released the first set of guidelines to editors on issuing retractions.

"These guidelines should help to reduce the extent and impact of scientific misconduct," Pickard said. "Ironically, greater detection may give the impression that fraudulent science is on the rise, when it is actually being mitigated by these policies."

Glen Schumock, director of the UIC Center for Pharmacoeconomic Research, assisted Pickard and Samp in the study, which was funded by the UIC College of Pharmacy and Takeda Pharmaceuticals U.S.A, Inc., which funded Samp's fellowship.


Story Source:

The above story is based on materials provided by University of Illinois at Chicago. Note: Materials may be edited for content and length.


Journal Reference:

  1. Jennifer C. Samp, Glen T. Schumock, A. Simon Pickard. Retracted Publications in the Drug Literature. Pharmacotherapy, 2012 DOI: 10.1002/j.1875-9114.2012.01100.x

Cite This Page:

University of Illinois at Chicago. "Facts in scientific drug literature may not be." ScienceDaily. ScienceDaily, 29 May 2012. <www.sciencedaily.com/releases/2012/05/120529181145.htm>.
University of Illinois at Chicago. (2012, May 29). Facts in scientific drug literature may not be. ScienceDaily. Retrieved October 30, 2014 from www.sciencedaily.com/releases/2012/05/120529181145.htm
University of Illinois at Chicago. "Facts in scientific drug literature may not be." ScienceDaily. www.sciencedaily.com/releases/2012/05/120529181145.htm (accessed October 30, 2014).

Share This



More Science & Society News

Thursday, October 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Obama: The US Will Not 'run and Hide' From Ebola

Obama: The US Will Not 'run and Hide' From Ebola

AP (Oct. 29, 2014) Surrounded by health care workers in the White House East Room, President Barack Obama said the U.S. will likely see additional Ebola cases in the weeks ahead. But he said the nation can't seal itself off in the fight against the disease. (Oct. 29) Video provided by AP
Powered by NewsLook.com
Lowe's Testing Robot Sales Assistants in California Store

Lowe's Testing Robot Sales Assistants in California Store

Buzz60 (Oct. 29, 2014) Lowe’s is testing out what it’s describing as a robotic shopping assistant in one of its Orchard Supply Hardware Stores in California. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
States And White House Disagree On Ebola Quarantines

States And White House Disagree On Ebola Quarantines

Newsy (Oct. 29, 2014) Officials in New Jersey and Maine have quarantined Doctors Without Borders nurse Kaci Hickox, a move the White House doesn't seem to support. Video provided by Newsy
Powered by NewsLook.com
New Wave of Online Delivery Gains Momentum

New Wave of Online Delivery Gains Momentum

AFP (Oct. 29, 2014) With start-ups like Postmates offering quick delivery of meals, groceries and other items through a smartphone app, the online world is delivering again. Duration: 01:39 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Science & Society

Business & Industry

Education & Learning

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



    Save/Print:
    Share:

    Free Subscriptions


    Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

    Get Social & Mobile


    Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

    Have Feedback?


    Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
    Mobile: iPhone Android Web
    Follow: Facebook Twitter Google+
    Subscribe: RSS Feeds Email Newsletters
    Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins